إعلان
إعلان
SBFM
Sunshine Biopharma Inc.
1.34
USDبرعاية
-0.03
-2.19%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
1.27
-0.07
-4.85%
تقارير أرباح SBFM
النسبة الإيجابية المفاجئة
SBFM تفوق 1 من 8 آخر التقديرات.
13%
التقرير التالي
بيانات التقرير القادم
٣٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$10.20M
/-$0.27
التغير الضمني من Q3 25 (Revenue/ EPS)
+8.31%
/+42.11%
التغير الضمني من Q4 24 (Revenue/ EPS)
+6.31%
/-73.00%
Sunshine Biopharma Inc. earnings per share and revenue
On ١٣ نوفمبر ٢٠٢٥, SBFM reported earnings of -0.19 USD per share (EPS) for Q3 25, missing the estimate of -0.13 USD, resulting in a -43.29% surprise. Revenue reached 9.42 مليون, compared to an expected 11.32 مليون, with a -16.82% difference. The market reacted with a -2.40% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -0.27 USD, with revenue projected to reach 10.20 مليون USD, implying an زيادة of 42.11% EPS, and زيادة of 8.31% in Revenue from the last quarter.
الأسئلة الشائعة
What were Sunshine Biopharma Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Sunshine Biopharma Inc. reported EPS of -$0.19, missing estimates by -43.29%, and revenue of $9.42M, -16.82% below expectations.
How did the market react to Sunshine Biopharma Inc.'s Q3 2025 earnings?
The stock price moved down -2.4%, changed from $1.67 before the earnings release to $1.63 the day after.
When is Sunshine Biopharma Inc. expected to report next?
The next earning report is scheduled for ٣٠ مارس ٢٠٢٦.
What are the forecasts for Sunshine Biopharma Inc.'s next earnings report?
Based on 3
المحللين, Sunshine Biopharma Inc. is expected to report EPS of -$0.27 and revenue of $10.20M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان